지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Objective: The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are frequently prescribed medications worldwide for the treatment of hypercholesterolemia. Statins are considered to be well tolerated; however, they have a potential for myotoxicity. Concomitant drugs that inhibit cytochrome P450 3A4 can increase the concentration of statins and thus the risk of developing myotoxicity. The purpose of this study was to evaluate risk factors associated with potential drug-drug interactions in patients receiving statins. Methods: The subjects of this study were patients aged more than 18 years who received at least one prescription of statins in a general hospital located in Chuncheon-si, Korea, between January 1, 2018, and March 31, 2018. Data regarding statin use and baseline characteristics was collected from the computerized hospital database. Logistic regression analysis was used to identify risk factors associated with potential drug-drug interactions. Results: A total of 1061 patients were finally included in the study. The incidence of potential drug-drug interactions was 45% in all subjects. According to the results of the multivariate logistic regression analysis, myocardial infarction as the indication of statin, arrhythmia or heart failure as a comorbidity, and aspartate aminotransferase levels higher than 40 IU/L were significant risk factors for potential drug-drug interactions in study subjects. Diltiazem was the most commonly co-prescribed drug that caused potential drug-drug interactions with statins. Conclusion: There was a considerable rate of potential drug-drug interactions in patients receiving statins. Health care professionals should attempt to reduce potential drug-drug interactions during statin administration
목차
등록된 정보가 없습니다.
참고문헌 (23)
참고문헌 신청
Catapano AL / 2016 / 2016 ESC/EAS guidelines for the management of dyslipidaemias / Eur Heart J 37(39):2999~3058
Bellosta S / 2018 / Statin drug interactions and related adverse reactions : an update / Expert Opin Drug Saf 17(1):25~37
Cziraky MJ / 2006 / Statin safety: an assessment using an administrative claims database / Am J Cardiol 97(8A):61C~68C
Omar MA / 2001 / Rhabdomyolysis and HMG-CoA reductase inhibitors / Ann Pharmacother 35(9):1096~1107
Becker ML / 2005 / Potential determinants of drug-drug interaction associated dispensing in community pharmacies / Drug Saf 28(5):371~378
Bellosta S / 2018 / Statin drug interactions and related adverse reactions : an update / Expert Opin Drug Saf 17(1):25~37
Cziraky MJ / 2006 / Statin safety: an assessment using an administrative claims database / Am J Cardiol 97(8A):61C~68C
Omar MA / 2001 / Rhabdomyolysis and HMG-CoA reductase inhibitors / Ann Pharmacother 35(9):1096~1107
Becker ML / 2005 / Potential determinants of drug-drug interaction associated dispensing in community pharmacies / Drug Saf 28(5):371~378
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Statin Supply and Polydrug Use in Older Adults: A Focus on Drug Combinations that Reduce Bone Density
Annals of geriatric medicine and research
2021 .12
-
Prevention of Intra-Abdominal Adhesions Using the Combination of Mixed Solid of Poloxamer, Gelatin and Chitosan (Mediclore®) and a Statin
대한외과학회 학술대회 초록집
2021 .05
-
Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?
지질·동맥경화학회지
2024 .01
-
Statin Intolerance: an Overview of the Current Status and Possible Treatment Options
지질·동맥경화학회지
2018 .01
-
스타틴과 당뇨병 발생 위험
대한의사협회지
2017 .01
-
Pilot Algorithm Designed to Help Early Detection of HMG-CoA Reductase Inhibitor-Induced Hepatotoxicity
Healthcare Informatics Research
2017 .07
-
The Relationship between Delirium and Statin Use According to Disease Severity in Patients in the Intensive Care Unit
Clinical Psychopharmacology and Neuroscience
2023 .02
-
Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism
Korean Circulation Journal
2018 .01
-
Low-Density Lipoprotein Cholesterol Level, Statin Use and Myocardial Infarction Risk in Young Adults
지질·동맥경화학회지
2022 .09
-
Effect of Coenzyme Q<sub>10</sub> Supplementation in Statin-Treated Obese Rats
Biomolecules & Therapeutics(구 응용약물학회지)
2016 .01
-
Effects of Statins for Primary Prevention in the Elderly: Recent Evidence
지질·동맥경화학회지
2020 .01
-
Clinical Characteristics of Patients With Statin Discontinuation in Korea: A Nationwide Population-Based Study
지질·동맥경화학회지
2024 .01
-
Statins in Acute Ischemic Stroke: A Systematic Review
대한뇌졸중학회지
2015 .01
-
스타틴이 총 사망률에 미치는 영향
대한내과학회지
2023 .02
-
Combination of Statin and Ezetimibe versus Statin Monotherapy on Cardiovascular Disease and Type 2 Diabetes Incidence among Adults with Impaired Fasting Glucose: a Propensity- Matched Nationwide Cohort Study
지질·동맥경화학회지
2021 .09
-
Efficacy and Safety of Prescription Omega-3 Fatty Acids Added to Stable Statin Therapy in Korean Patients with Type 2 Diabetes and Hypertriglyceridemia: a Randomized Controlled Trial
지질·동맥경화학회지
2019 .01
-
Intensity of Statin Treatment in Korean Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol
지질·동맥경화학회지
2019 .01
-
Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval
Journal of Korean Medical Science
2024 .04
-
Layer-by-layer assembled polymeric thin films as prospective drug delivery carriers: design and applications
생체재료학회지
2018 .12
-
Impact of Statin Treatment Intensity after Endovascular Revascularization on Lower Extremity Peripheral Artery Disease
Yonsei Medical Journal
2022 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0